AI Assistant
Blog
Pricing
Log In
Sign Up
Two-year Results of Sustained-Release Leuprorelin Acetate (TAP-144-SR) Treatment in Children with Central Precocious Puberty
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
